Welcome to Global Good’s Impact Interview series. This series is designed to tell the stories of the people and companies working to drive impact in society.
In this edition, we speak with Scott, founder of Sensore, about translating materials science research into preventive healthcare technology, the quiet scale of avoidable harm caused by pressure ulcers in the UK, and why the most valuable role for technology in healthcare is often not dramatic intervention but earlier prevention.
Can you introduce yourself and tell us about your role?
I’m Scott, the founder of Sensore. We are building a smart-fabric pressure sensing solution designed to continuously monitor pressure and help identify risk early, so pressure ulcers can be prevented before they develop.
I founded the company during the third year of my PhD in Materials Science at the University of Manchester, and since then have been on a mission to understand the true scale of pressure ulcers in the UK, and to create technology that supports better prevention for people at risk, their families, and the professionals who care for them.
How did your company come about and what was the motivation behind it?
Sensore was founded out of a clear and persistent frustration: pressure ulcers remain widespread, costly, and devastating, despite being largely preventable. Too often, prevention relies on manual processes and intermittent checks, placing an unsustainable burden on patients, families, and already overstretched care teams.
With a background in materials science, printed electronics, and smart textiles, I could see that the technology existed to do better. The motivation behind Sensore was to translate advanced materials research into something practical, comfortable, and scalable – a solution that could quietly monitor pressure in real time and support prevention before harm occurs.
At its core, the company was created to shift pressure care from a reactive model to a proactive one. The ambition is not incremental improvement, but systemic change: making high-quality pressure ulcer prevention accessible across hospitals, care homes, and people’s own homes, and ensuring that avoidable harm is identified early rather than treated late.
Can you describe your company’s mission and values?
Our mission is to eradicate pressure ulcers by making preventive technology smarter, more accessible, and more comfortable for everyone who needs it.
We are developing Sensore as a tool that can quietly and reliably monitor pressure, flag risk patterns early, and support timely offloading and repositioning. The goal is to enable better care decisions and greater independence across home, community, and clinical settings.
Our values sit across four pillars:
- Innovation with Impact: using advanced materials and sensing to deliver measurable improvements in people’s lives.
- User-Centric Design: co-designing with end users and frontline professionals from day one, to make sure our solution fits real life.
- Integrity and Trust: committing to rigorous validation, transparency, robust data privacy, and ethical use of AI.
- Empowerment: giving people at risk and those who support them clearer feedback and more control to prevent harm.
What are some of the most pressing social issues that your company is working to address through its technology?
Pressure ulcers sit at the intersection of avoidable harm, workforce strain, and inequality in access to high-quality prevention. In the UK, estimates suggest over 700,000 people develop a pressure ulcer each year, with treatment costs cited at around £2.6 billion annually. Guidance and research also indicate that a large proportion are preventable with effective monitoring and timely pressure relief.
Sensore is tackling this by widening access to data-driven prevention. By standardising prevention across settings – from hospitals to care homes to people’s own homes – we aim to reduce avoidable harm, support stretched health and social care teams, and help close gaps in care quality. More broadly, it is part of the shift from reactive treatment to proactive, preventative care.
How does your company measure the impact of its work in creating positive change?
We focus on impact that matters to users, clinicians, and the health system, across three levels:
1. Usability and adoption: prevention only works if people will actually use it. We assess comfort, intrusiveness, and ease of use using established tools (such as the System Usability Scale), workload measures, and real engagement data, for example how often users respond to prompts or adjust posture using live feedback.
2. Behavioural and clinical indicators: in the short term we track whether the system reduces sustained high-pressure events and supports timely offloading. Over time, the key outcomes are reductions in ulcer incidence and severity in real-world settings, alongside improvements in reported comfort, confidence, and quality of life.
3. Service impact and economics: we model the effect on staff time, length of stay, and cost of care, using real-world data to understand what level of ulcer reduction would justify investment and how prevention changes workflow.
In your opinion, what impact will technology have in creating a better future?
In healthcare, the most valuable role for technology is often not dramatic intervention, but earlier prevention. Many harms become expensive crises because we only see them after the fact. When sensing becomes low-friction and continuous, it can shift care from periodic checks to timely, individualised action.
For pressure ulcers specifically, current practice often depends on intermittent assessment and repositioning routines. Continuous pressure mapping offers a different model: detect risk as it emerges, then guide pressure relief in the moment. That is not about replacing clinical judgement, but about making risk visible between clinical touchpoints, including at home and in social care settings.
What advice do you have for other companies looking to use tech for good and positively impact the world?
Start by defining the human problem in operational terms: who is being harmed, where it happens, how often it happens, and which decisions need to change to reduce that harm. If you cannot describe the workflow and constraints clearly, you will likely build something that looks impressive but ends up switched off.
Design with users and frontline professionals from the beginning, especially groups who are often under-represented. Inclusion is not just a values statement: it improves safety, usability, and generalisability.
Treat evidence, regulation, and data governance as core product features. In healthcare, impact is not a slogan – it is demonstrated through usability, safety, and outcomes in real settings. Define success criteria early, plan studies early, and be disciplined about claims until the data supports them.
Finally, align incentives with outcomes. If your business model rewards deployment rather than improved results, you will drift. Measure impact honestly, iterate transparently, and choose partners who care about outcomes as much as adoption.
–
Scott’s perspective captures something important about the next chapter of healthcare innovation: that meaningful change often comes not from dramatic breakthroughs, but from making the invisible visible. Pressure ulcers cause hundreds of thousands of people avoidable harm each year and cost the UK billions, yet remain a problem largely addressed through intermittent checks and stretched human attention. Sensore’s approach — embedding sensing into the fabric of everyday care — represents a quiet but significant shift toward continuous, preventative healthcare. It is also a reminder that the most impactful tech-for-good companies are often the ones disciplined enough to measure honestly, design inclusively, and resist the pull of adoption metrics that don’t reflect real outcomes.
Sensore is supported by Accelerate Associates, who support the Super Connect Series powered by Empact Ventures in partnership with Global Good.
